| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | -96.8% | -73.8% |
| Cost of Revenue | $1.0M | -96.1% | -38.2% |
| R&D Expense | $7.1M | +60.4% | +133.2% |
| SG&A Expense | $4.8M | -12.8% | -0.7% |
| Operating Income | -$10.2M | -122.4% | -1985.8% |
| Pre-tax Income | -$8.4M | -117.7% | -546.2% |
| Income Tax | -$2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $172.0M | -5.8% | +73.2% |
| Accounts Receivable | $2.5M | -61.6% | -79.4% |
| Inventory | $48.0M | +34.8% | -22.6% |
| Current Assets | $227.7M | -0.6% | +26.0% |
| Total Assets | $231.6M | -1.6% | +18.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $60.3M | — | — |
| Capital Expenditures | $314K | — | — |
| Investing Cash Flow | -$314K | — | — |
| Financing Cash Flow | -$43.5M | — | — |
| Free Cash Flow | $60.0M | — | — |
| -116.9% |
| -476.4% |
| Net Income | -$6.4M | -117.9% | -573.7% |
| EPS (Basic) | -$0.09 | -118.0% | -550.0% |
| EPS (Diluted) | -$0.09 | -118.4% | -550.0% |
| $24.8M |
| +9.4% |
| +11.4% |
| Total Liabilities | $28.1M | +8.1% | +8.5% |
| Stockholders' Equity | $203.5M | -2.8% | +20.1% |